NASDAQ · Drug Manufacturers - Specialty & Generic

ACB (ACB) Stock

$2.72 -0.73% NASDAQ: ACB Healthcare

Valuation

MetricValue
Price$2.72
Market Cap$168.48M
P/E Ratio115.33
P/B Ratio0.35
P/S Ratio0.74
EPS (TTM)$0.03
52-Week High$6.67
52-Week Low$2.65
Dividend Yield0.00%

Financials & Margins

MetricValue
ROE0.35%
ROA0.24%
ROCE0.83%
Gross Margin1.46%
Operating Margin1.46%
Net Margin-11.71%
Debt/Equity0.19
Current Ratio4.33

Annual Financials (USD)

Metric20212022202320242025
Revenue$245.0M$221.0M$224.0M$270.0M$343.0M
Operating Profit$-283.0M$-231.0M$-207.0M$-46.0M$5.0M
Net Profit$-694.0M$-1.7B$-817.0M$-69.0M$2.0M
EPS$-40.92$-79.92$-8.17$-1.28$0.03
Op Margin-115.3%-104.6%-92.6%-17.2%1.4%

Balance Sheet (USD)

Metric20212022202320242025
Total Assets$2.7B$926.0M$926.0M$840.0M$848.0M
Total Liabilities$686.0M$405.0M$405.0M$237.0M$243.0M
Cash$440.0M$301.0M$301.0M$180.0M$184.0M
Borrowings$399.0M$226.0M$226.0M$100.0M$104.0M

Latest News

ACB Stock Down 28% in Three Months: Time to Buy the Dip or Cash Out? Zacks · Jul 15, 2026 Weekly Roundup on the Cannabis Sector & Psychedelic Sector Market Exclusive · Jul 13, 2026 Aurora Named to TIME Canada's Best Companies 2026 List CNW Group · Jul 9, 2026 VFF Stock Loses 27% in Three Months: Time to Invest or Exit? Zacks · Jul 8, 2026 Aurora Cannabis Inc. Announces Filing and Mailing of the Management Information Circular in Connection with the Annual General Meeting of Shareholders CNW Group · Jul 8, 2026

Cash Flow (USD)

Metric20212022202320242025
Operating Cash Flow$-211.0M$-110.0M$-116.0M$-69.0M$16.0M
Investing Cash Flow$-80.0M$-68.0M$-39.0M$-20.0M$-33.0M
Financing Cash Flow$-21.0M$-32.0M$-95.0M$0$0
Net Cash Flow$259.0M$16.0M$-140.0M$-119.0M$2.0M
Free Cash Flow$-264.0M$-142.0M$-128.0M$-85.0M$-3.0M

Valuation & Return Ratios

MetricValue
PEG Ratio—
EV / EBITDA4.15
FCF Yield-11.56%
Quick Ratio1.48
Interest Coverage0.63
Return 1Y-41.92%
Return 3Y-50.19%
Return 5Y-96.38%

Ownership

Insiders Held1.27%
Institutions Held9.70%
Institutions Float Held9.83%
Institutional HolderSharesReport Date
Tidal Investments LLC1,249,6672026-03-31
Goldman Sachs Group Inc1,056,2182026-03-31
Renaissance Technologies, LLC758,1812026-03-31
National Bank of Canada/FI/271,2902026-03-31
Morgan Stanley259,0552026-03-31

Peer Comparison

TickerPriceChangeP/EMarket CapDiv Yield
ACRS $5.91 -2.96% -6.68 $825.41M 0.00%
BIOA $20.88 -4.09% -9.34 $786.12M 0.00%
CGC $0.92 +4.02% -0.20 $390.20M 0.00%
EDIT $2.62 -2.24% -1.39 $256.50M 0.00%
HITI $2.12 -0.93% -3.87 $186.28M 0.00%

About ACB

ACB is led by CEO Miguel Martin, employs 1,073 people, headquartered in CA, publicly traded since 2014.

ACB stock trades at $2.72 with a market capitalization of $168.48M. The stock is valued at a price-to-earnings (P/E) ratio of 115.33, price-to-book of 0.35, price-to-sales of 0.74. Over the past 52 weeks the stock has ranged between $2.65 and $6.67, and currently trades 59.2% below its 52-week high.

On profitability, ACB generates a return on equity (ROE) of 0.35%, return on capital employed of 0.83%, an operating margin of 1.46%, a net profit margin of -11.71%.

Related Healthcare Stocks

LLY Drug Manufacturers - General $1185.71 -0.52% JNJ Drug Manufacturers - General $259.24 +0.88% ABBV Drug Manufacturers - General $246.04 +0.89% UNH Medical - Healthcare Plans $407.08 +0.77% MRK Drug Manufacturers - General $128.57 +0.16% NVS Drug Manufacturers - General $158.83 -0.64% NVO Biotechnology $51.58 +1.22% TMO Medical - Diagnostics & Research $594.00 +2.41% AMGN Drug Manufacturers - General $387.64 -1.39% ABT Medical - Devices $108.03 +0.70% GILD Drug Manufacturers - General $132.73 -1.18% PFE Drug Manufacturers - General $26.74 +2.06%

Popular Stocks

Apple (AAPL)Microsoft (MSFT)NVIDIA (NVDA)Alphabet (GOOGL)Amazon (AMZN)Meta (META)Tesla (TSLA)Broadcom (AVGO)JPMorgan (JPM)Visa (V)

Screens featuring this stock

High ROE Healthcare StocksLow P/E Healthcare StocksHigh Net Margin Healthcare StocksDividend Healthcare StocksLow Debt Healthcare StocksNasdaq High ROE StocksAll stock screens
Run Stock Screener Investing Guides